Abstract: A method of treating an inanimate surface to provide malodor removal and/or malodor prevention includes treating the surface with a composition including at least 102 cfu/g of bacterial spores wherein the bacterial spores are selected from the group consisting of spores of Bacillus amyloliquefaciens strain D747 and a variant thereof, wherein the variant has at least 96% and preferably at least 99% whole genome sequence identity with Bacillus amyloliquefaciens strain D747.

Abstract: The present invention relates to methods and polypeptides for detecting a compound in a sample. In particular, the present invention relates to the use of a cell-free composition comprising at least one G protein coupled receptor embedded in a lipid Mayer which when expressed in a cell the N-terminus of the G protein coupled receptor, or subunits thereof, is outside the cell and the C-terminus is inside the cell, and which is capable of binding the compound. Optionally, the composition also comprises at least one accessory molecule that directly or indirectly binds an intracellular loop and/or the C-terminus of the G protein coupled receptor. The G protein coupled receptor, and/or accessory molecule when present, in combination comprise a bioluminescent protein and an acceptor molecule, which enables bioluminescent resonance energy transfer (BRET) to be used to detect the compound binding the receptor.

Abstract: The present invention relates to methods and polypeptides for detecting a compound in a sample. In particular, the present invention relates to the use of a cell-free composition comprising at least one G protein coupled receptor embedded in a lipid Mayer which when expressed in a cell the N-terminus of the G protein coupled receptor, or subunits thereof, is outside the cell and the C-terminus is inside the cell, and which is capable of binding the compound. Optionally, the composition also comprises at least one accessory molecule that directly or indirectly binds an intracellular loop and/or the C-terminus of the G protein coupled receptor. The G protein coupled receptor, and/or accessory molecule when present, in combination comprise a bioluminescent protein and an acceptor molecule, which enables bioluminescent resonance energy transfer (BRET) to be used to detect the compound binding the receptor.

Abstract: A novel oral pharmaceutical composition comprising extrusion granules of a mixture comprised of 50 to 70% by weight of clometacine, 5 to 20% by weight of an alkali metal carbonate and an anhydrous excipient for non aqueous granulation having a rapid action and a very strong increased total biodisponibility and a method of relieving pain in warm-blooded animals.

Abstract: The invention comprises a liquid storage tank having a floating roof of the type in which the roof rises and falls with changes in the level of the liquid and a seal provided between the edge of the roof and the inner wall of the tank to prevent contamination or evaporation of the liquid and to allow for any out of truth of the tank and any lateral movement of the roof having the seal supported between a side wall of the roof and the tank wall in the form of a continuous annular bag of rubber or plastics coated fabric comprising inner and outer chambers the inner chamber lying in contact with the side wall of the floating roof and containing a liquid and the outer chamber lying in contact with the tank wall and containing a pre-shaped pad of a synthetic foam material, the whole being supported from the roof by bolts which pass through the top edge of the seal bag.